Sarah joined CellCentric in June 2026.

She brings extensive experience in global clinical trial operations across infectious disease, vaccines, diagnostics, and pediatrics. Her background spans both sponsor and NHS research environments, with a strong focus on high quality study delivery, cross functional coordination, and inspection ready documentation management.

Sarah’s expertise includes study start up and feasibility, eTMF oversight, vendor coordination, data quality management, budget tracking, and operational support across all phases of clinical development.

Prior to joining CellCentric, Sarah worked as a Senior Global Clinical Trial Associate at Janssen (Johnson & Johnson), supporting global study teams across multiple therapeutic areas. She has also held clinical research roles at Qiagen, the NHS Manchester University Foundation Trust, where she led the first Covid trial in Pediatrics, and the University of Oxford’s national Covid-19 Infection Survey.

Earlier in her career, she worked as a Biobank Scientist at AstraZeneca, supporting GLP/GCP compliant sample handling and human tissue governance.

Sarah holds a BSc (Hons) in Biomedical Science and maintains up to date Good Clinical Practice (GCP) certification.

Sarah has been involved in organizing charity initiatives through women’s empowerment groups.